Development of novel formulations containing Lysozyme and Lactoferrin and evaluation of antibacterial effects on Mutans Streptococci and Lactobacilli

Tonguc-Altin K., Sandalli N., Duman G., Selvi-Kuvuetli S., Topcuoglu N., Kulekci G.

ARCHIVES OF ORAL BIOLOGY, cilt.60, sa.5, ss.706-714, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 60 Sayı: 5
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.archoralbio.2015.02.004
  • Dergi Adı: ARCHIVES OF ORAL BIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.706-714
  • Anahtar Kelimeler: Lysozyme and Lactoferrin, Liposome, Poloxamer 407, Antibacterial effect, PHOSPHOLIPID LIPOSOMES, BIOFILM FORMATION, POLOXAMER 407, IN-VITRO, DELIVERY, SALIVA, LACTOPEROXIDASE, HYDROXYAPATITE, MICROORGANISMS, CHLORHEXIDINE
  • İstanbul Üniversitesi Adresli: Evet

Özet

Objective: The aim of this study was to determine the antibacterial effect of different formulations containing Lysozyme and Lactoferrin and drug delivery system as well as poloxamer 407 with the trade name of Pluronic F-127 and/or freeze dried liposome containing DOTAP [freeze dried Liposomal DOTAP] on Streptococcus sobrinus, Streptococcus mutans and Lactobacillus acidophilus in comparison with 0.2% chlorhexidine.